Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 11, Issue 4

July-August 2014

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Features
News and Reports
Op Ed
President’s Column

Ask the Hematologist

Anti-Phospholipid Antibodies and Pregnancy

Deepa Suryanarayan, MD,David Garcia, MD

View Articletitled, Anti-Phospholipid Antibodies and Pregnancy

Clinical Trials Corner

Validating Activated CSF3R Signaling as a Therapeutic Target in CNL and Atypical CML

Jason Gotlib, MD, MS

View Articletitled, Validating Activated CSF3R Signaling as a Therapeutic Target in CNL and Atypical CML

Diffusion

Red Cells, RNA, and Regulation: The Plot Thickens

Theresa Coetzer, PhD

View Articletitled, Red Cells, RNA, and Regulation: The Plot Thickens

Collective Action at the Cell Surface: Antibodies Club Together to Activate Complement

Peter Johnson, MD

View Articletitled, Collective Action at the Cell Surface: Antibodies Club Together to Activate Complement

NF-κB is Key in Mantle Cell Lymphoma

Ann S. LaCasce, MD, MSc

View Articletitled, NF-κB is Key in Mantle Cell Lymphoma

Lymphoid Cancers Thwart Marrow Response to Therapeutic Antibodies, But Chemotherapy Triggers “ASAP” to Save the Day

Pamela S. Becker, MD, PhD

View Articletitled, Lymphoid Cancers Thwart Marrow Response to Therapeutic Antibodies, But Chemotherapy Triggers “ASAP” to Save the Day

Refining Anticoagulation with Dabigatran: Can We RE-LY on a No-Monitoring Paradigm?

Carlos H. Villa, MD, PhD,Adam Cuker, MD, MS

View Articletitled, Refining Anticoagulation with Dabigatran: Can We RE-LY on a No-Monitoring Paradigm?

Yet Another Mechanism of Action for Hydroxyurea in Sickle Cell Disease?

Charles T. Quinn, MD, MS

View Articletitled, Yet Another Mechanism of Action for Hydroxyurea in Sickle Cell Disease?

Skip the Shake and Mind the Marrow

Daniel L. Marks, MD,Peter Kurre, MD

View Articletitled, Skip the Shake and Mind the Marrow

The von Willebrand Factor Assembly Line Gets Longer

Pete Lollar, MD

View Articletitled, The von Willebrand Factor Assembly Line Gets Longer

Fox Drives CAR Cells in Niche

Mark J. Koury, MD

View Articletitled, Fox Drives CAR Cells in Niche

Features

Looking Back – Looking Forward: 40 Years in Hemophilia Research

Gilbert C. White II, MD

View Articletitled, Looking Back – Looking Forward: 40 Years in Hemophilia Research

News and Reports

Visitors’ Bureau – A Preview of the 2014 ASH Annual Meeting

View Articletitled, Visitors’ Bureau – A Preview of the 2014 ASH Annual Meeting

Op Ed

“Ask and Ye Shall Receive” – Women, Stand Up and Be Counted!

Nancy Berliner, MD,Cynthia E. Dunbar, MD,Susan B. Shurin, MD,Janis L. Abkowitz, MD

View Articletitled, “Ask and Ye Shall Receive” – Women, Stand Up and Be Counted!

President’s Column

Need Research Support? Think ASH!

Linda J. Burns, MD

View Articletitled, Need Research Support? Think ASH!

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

Anti-Phospholipid Antibodies and Pregnancy

Clinical Trials Corner

Validating Activated CSF3R Signaling as a Therapeutic Target in CNL and Atypical CML

Diffusion

Red Cells, RNA, and Regulation: The Plot Thickens

Collective Action at the Cell Surface: Antibodies Club Together to Activate Complement

NF-κB is Key in Mantle Cell Lymphoma

Lymphoid Cancers Thwart Marrow Response to Therapeutic Antibodies, But Chemotherapy Triggers “ASAP” to Save the Day

Refining Anticoagulation with Dabigatran: Can We RE-LY on a No-Monitoring Paradigm?

Yet Another Mechanism of Action for Hydroxyurea in Sickle Cell Disease?

Skip the Shake and Mind the Marrow

The von Willebrand Factor Assembly Line Gets Longer

Fox Drives CAR Cells in Niche

Features

Looking Back – Looking Forward: 40 Years in Hemophilia Research

News and Reports

Visitors’ Bureau – A Preview of the 2014 ASH Annual Meeting

Op Ed

“Ask and Ye Shall Receive” – Women, Stand Up and Be Counted!

President’s Column

Need Research Support? Think ASH!

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Features

News and Reports

Op Ed

President’s Column

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only